Partnership

Bayer and Samsung Collaborate to Address Sleep Disturbances in Menopause

Bayer has announced a strategic partnership with Samsung Electronics America to address sleep disturbances associated with menopause (SDM). This collaboration aims to fill data gaps and improve understanding of the impact of SDM on women’s health and quality of life through an observational study using data from Samsung consumer devices. Menopausal sleep disturbances, affecting up to 60% of women during the transition,…

Novo Nordisk Foundation, Wellcome & Gates Foundation Commit $300M to Advance Global Health Equity

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have joined forces to advance global health equity. This partnership, announced at the Novo Nordisk Foundation’s Global Science Summit in Denmark, involves a substantial commitment of $300 million over three years to support critical scientific research and development (R&D) aimed at addressing pressing global health challenges. The objective of this…

Endometriosis Australia Partners with CHARLI App to Tackle Diagnosis Delays

Endometriosis, a condition impacting approximately 1 in 7 Australian females and individuals assigned female at birth (AFAB), presents significant challenges due to its debilitating symptoms and diagnostic complexities. In response to these challenges, the CHARLI app has been introduced in collaboration with Endometriosis Australia, aiming to enhance reproductive health tracking and management, particularly for those living with endometriosis. The initiative was spearheaded…

Menopause Virtual Clinic Midi Health and Caregiver Support Platform Cleo Partner to Enhance Support for Women during Midlife Hormonal Transition

Midi Health, a virtual care clinic specializing in women’s health during perimenopause and menopause, has teamed up with Cleo, a global caregiving platform, to provide comprehensive support for women facing hormonal changes. The collaboration aims to address the specific healthcare needs of women during this critical phase of their lives. The partnership between Midi Health and Cleo allows for personalized guidance and…

Bloomlife and Valley Perinatal Services Partner to Advance High-Risk Pregnancy Care

Women’s health startup Bloomlife and Valley Perinatal Services (VPS), Arizona’s top provider of care for high-risk pregnancies, have announced a partnership to improve care for high-risk pregnancies through Bloomlife’s remote maternal care platform, Bloomlife Connects. The platform, that recently received FDA approval, integrates connected devices with data analytics to enhance the monitoring and management of high-risk pregnancies, initially focusing on hypertension, a…

Maternal Health Company Mother Goose Launches Breastfeeding Support Services in Collaboration with New Strategic Partners

Mother Goose Health, a digital maternal health platform, has announced the addition of a new lactation service. This service is part of a strategic collaboration with Nest Collaborative, a leading virtual lactation consultation provider, and The Breastfeeding Shop, which supplies quality breast pumps. The partnership aims to improve new mothers’ access to crucial breastfeeding support, aligning with their personal lactation goals. The…

Sexual Healthcare Provider TBD Health Launches B2B Services, Partners with FOLX Health and Wisp

TBD Health, a hybrid sexual healthcare provider known for its innovative clinical care, is expanding into the B2B healthcare market. This strategic move allows digital health companies such as FOLX Health and Wisp to leverage TBD Health’s comprehensive STD/STI at-home test kits, diagnostic laboratory services, and clinical care hubs. The collaboration aims to provide equitable, stigma-free, and reliable healthcare, according to Stephanie…

Organon Expands European Portfolio with Lilly Migraine Medicines

Organon and Eli Lilly and Company (Lilly) have announced a commercialization agreement that positions Organon as the exclusive distributor and promoter of two migraine medicines, Emgality (galcanezumab) and RAYVOW (lasmiditan), in Europe. Organon, a global healthcare company with a focus on women’s health, will leverage its experience in central nervous system disorders to promote and distribute these medications. Emgality is a humanized…